The investor presentation quantifies the covid market at 6.3 bil...

The investor presentation quantifies the covid market at 6.3 bil - for a company that compares in quality to QIAGEN - on track to deliver 30% of the revenue of Aus medical heavy hitters like NAN

‘they sleeping giant here is the STI kits - STI market at over 1 billion - STI rates going through the roof - see NSW health data for proof - one test that can detect 15 diseases is a game changer ; as a participant in IVF with my partner STI testing is mandatory - the current testing is patchy and difficult - multiple blood tests / swabs and only tests for 3 or 4 diseases; GSS can test for upto 12 in one swab! STI Kit simultaneously detects the 12 most commonly encountered STIs and has superior multiple infection detection over traditional methods - https://geneticsignatures.com/au/wp-content/uploads/sites/2/Genetic-Signatures-GSS-launches-new-STI-detection-kit.pdf

see recent alert out due to syphillis - https://www2.health.vic.gov.au/about/news-and-events/healthalerts/congenital-syphilis 6 DAYS AGO VICTORIA IS EXPERIENCING AN UPSURGE IN syphillis - causing severe congenital defects

with ongoing pressure on the health system the multi-testing capability across multiple medical indications is a sleeping giant. Well done Aus